Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302


The cost impact of short-term ventricular assist devices and extracorporeal life support systems therapies on the National Health Service in the UK.

Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Firmin R, Yonan N.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):41-8. doi: 10.1093/icvts/ivu078. Epub 2014 Mar 25.


The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.


Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.

Marasco SF, Lo C, Murphy D, Summerhayes R, Quayle M, Zimmet A, Bailey M.

Artif Organs. 2016 Jan;40(1):100-6. doi: 10.1111/aor.12496. Epub 2015 May 15.


Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes.

Takayama H, Soni L, Kalesan B, Truby LK, Ota T, Cedola S, Khalpey Z, Uriel N, Colombo P, Mancini DM, Jorde UP, Naka Y.

Circ Heart Fail. 2014 Sep;7(5):799-806. doi: 10.1161/CIRCHEARTFAILURE.113.000271. Epub 2014 Jul 15.


Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.

Takeda K, Garan AR, Topkara VK, Kirtane AJ, Karmpaliotis D, Kurlansky P, Yuzefpolskaya M, Colombo PC, Naka Y, Takayama H.

Eur J Cardiothorac Surg. 2017 Mar 1;51(3):591-596. doi: 10.1093/ejcts/ezw349.


Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.

Guenther S, Theiss HD, Fischer M, Sattler S, Peterss S, Born F, Pichlmaier M, Massberg S, Hagl C, Khaladj N.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):283-91. doi: 10.1093/icvts/ivt505. Epub 2013 Dec 13.


Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting.

Maini B, Gregory D, Scotti DJ, Buyantseva L.

Catheter Cardiovasc Interv. 2014 May 1;83(6):E183-92. doi: 10.1002/ccd.25247. Epub 2014 Jan 13.


Cardiac extracorporeal life support: state of the art in 2007.

Cooper DS, Jacobs JP, Moore L, Stock A, Gaynor JW, Chancy T, Parpard M, Griffin DA, Owens T, Checchia PA, Thiagarajan RR, Spray TL, Ravishankar C.

Cardiol Young. 2007 Sep;17 Suppl 2:104-15. doi: 10.1017/S1047951107001217. Review.


National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis.

Stretch R, Sauer CM, Yuh DD, Bonde P.

J Am Coll Cardiol. 2014 Oct 7;64(14):1407-15. doi: 10.1016/j.jacc.2014.07.958.


Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.

Loforte A, Marinelli G, Musumeci F, Folesani G, Pilato E, Martin Suarez S, Montalto A, Lilla Della Monica P, Grigioni F, Frascaroli G, Menichetti A, Di Bartolomeo R, Arpesella G.

Artif Organs. 2014 Jul;38(7):E129-41. doi: 10.1111/aor.12317. Epub 2014 May 20.


Extracorporeal life support in cardiogenic shock: Impact of acute versus chronic etiology on outcome.

Tarzia V, Bortolussi G, Bianco R, Buratto E, Bejko J, Carrozzini M, De Franceschi M, Gregori D, Fichera D, Zanella F, Bottio T, Gerosa G.

J Thorac Cardiovasc Surg. 2015 Aug;150(2):333-40. doi: 10.1016/j.jtcvs.2015.02.043. Epub 2015 Feb 28.


Short-term mechanical circulatory support by veno-arterial extracorporeal membrane oxygenation in the management of cardiogenic shock and end-stage heart failure.

Brugts JJ, Caliskan K.

Expert Rev Cardiovasc Ther. 2014 Feb;12(2):145-53. doi: 10.1586/14779072.2014.880051. Epub 2014 Jan 13.


Evaluation of the ventricular assist device programme in the UK.

Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, Freeman C.

Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. Review.


Left ventricular assist devices: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2004;4(3):1-69. Epub 2004 Mar 1.


Thoratec CentriMag for temporary treatment of refractory cardiogenic shock or severe cardiopulmonary insufficiency: a systematic literature review and meta-analysis of observational studies.

Borisenko O, Wylie G, Payne J, Bjessmo S, Smith J, Yonan N, Firmin R.

ASAIO J. 2014 Sep-Oct;60(5):487-97. doi: 10.1097/MAT.0000000000000117. Review.


The Papworth experience with the Levitronix CentriMag ventricular assist device.

Shuhaiber JH, Jenkins D, Berman M, Parameshwar J, Dhital K, Tsui S, Large SR.

J Heart Lung Transplant. 2008 Feb;27(2):158-64. doi: 10.1016/j.healun.2007.10.015.


Costs associated with ventricular assist device use in children.

Mahle WT, Ianucci G, Vincent RN, Kanter KR.

Ann Thorac Surg. 2008 Nov;86(5):1592-7. doi: 10.1016/j.athoracsur.2008.07.022.


Adequate systemic perfusion maintained by a CentriMag during acute heart failure.

Favaloro RR, Bertolotti A, Diez M, Favaloro L, Gomez C, Peradejordi M, Trentadue J, Hellman L, Arzani Y, Otero PV.

Tex Heart Inst J. 2008;35(3):334-9.


Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival.

Mohite PN, Sabashnikov A, Patil NP, Sáez DG, Zych B, Popov AF, Weymann A, Wahlers T, Marczin N, DeRobertis F, Bahrami T, Amrani M, Simon AR.

J Artif Organs. 2014 Sep;17(3):228-35. doi: 10.1007/s10047-014-0773-1. Epub 2014 Jun 1.


Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.

Noly PE, Kirsch M, Quessard A, Leger P, Pavie A, Amour J, Leprince P.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):49-55. doi: 10.1093/icvts/ivu072. Epub 2014 Mar 21.


Supplemental Content

Support Center